We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

The COVID-19 Pandemic – News and Features

News

CRISPR-Based Method Enables Ultrasensitive Detection of Nucleic Acids

An engineered CRISPR-based method that finds RNA from SARS-CoV-2, the virus that causes COVID-19, promises to make testing for that and other diseases fast and easy.
Industry Insight

Building a More Resilient Biopharma Industry

Technology Networks spoke to Conor McKechnie, to learn more about the Biopharma Resilience Index and the changes required to get new therapeutics to market quicker.
News

Stopping the Immune System’s Lethal Lung Response

Researchers have discovered a drug candidate that, in mice, can prevent lethal lung inflammation by inhibiting a protein called PTP1B.
News

DNA Nets Capture SARS-CoV-2 in Low-Cost Testing Platform

Tiny nets woven from DNA strands can ensnare the spike protein of the virus that causes COVID-19, lighting up the virus for a fast-yet-sensitive diagnostic test.
News

People Infected With COVID-19 Are at an Elevated Risk of Neurological Conditions

The post-COVID brain is at higher risk of developing neurological conditions including movement disorders, strokes, cognitive and memory problems, anxiety and migraines in the first year after infection, according to new research.
News

Mutation Linked to Alzheimer’s Disease Is Also Associated With COVID Mortality

It may be the most baffling quirk of COVID: What manifests as minor, flu-like symptoms in some individuals spirals into severe disease, disability, or even death in others. A new paper published in Nature may explain the genetic underpinnings of this dichotomy.
News

AI-Based Screening Method May Improve Discovery of New Drugs

Researchers have been able to identify promising drug candidates with up to 97% accuracy using an AI-based technique that models drug and target protein interactions.
Industry Insight

“Rewriting the Textbook” for Precision Medicine

Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.
News

Newly Discovered Barrier Prevents Immunity From Reaching Smell-Sensing Cells

A previously unknown barrier separates the bloodstream from the smell-sensing cells in mice, likely as a mechanism of protecting the brain, but may hinder the effectiveness of vaccines.
News

Killer Cells Get Better With Age

Up until now it had been widely assumed that the ability of killer T cells to destroy tumor cells and pathogens would deteriorate with age. It turns out, however, that the opposite is true – they become better killers, the older they get.
Advertisement